ASHPOfficial

Clinical Highlights from the 2020 Midyear: Therapeutic Debates 2020: Anticoagulation in Patients with End Stage Renal Disease

In this debate style presentation from the 2020 Midyear Clinical Meeting, our content matter experts examine the pros and cons of DOACs and Warfarin in patients with End Stage Renal Disease through a review of the literature. Who will you convince you? Listen in and decide!

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Vancomycin Therapeutic Drug Monitoring — The Times They Are a Changin’

Preview this BCCCP and BCPS recertification offering from the Midyear Clinical Meeting. This episode will review the current paradigm shift from trough concentration-guided vancomycin dosing and therapeutic drug monitoring (TDM) to area under the concentration-time curve (AUC)-guided vancomycin dosing and TDM and will prepare pharmacists for this paradigm shift and provide real-world examples of AUC monitoring implementation by multiple methods. Like what you hear and want to hear the rest and apply what you learn for recertification credit? Purchase the recertification product here.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Exploring Residency Programs: A Focus on Pharmacogenomics

Pharmacogenomics is a unique area of practice that student pharmacists may not know very much about. This podcast episode provides an overview of pharmacogenomic residency opportunities so that students may consider this avenue for post-graduate training.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

COVID-19: Care of the Critically Ill Patient: Part Two: A Focus on the Management of Coagulopathy

In Part Two of this podcast series (straight from the 2020 Midyear Clinical Meeting), Dr. Igneri describes the clinical manifestations of COVID-19 associated coagulopathy, shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated coaguopathy.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Ambulatory Care Residency Training: Identifying the Best Fit

Are you a student pharmacist seeking to learn more about ambulatory care practice and residency training? With the vast array of training options, including residency programs with ambulatory care tracks, it may be difficult to identify the best fit for you. This podcast episode reviews various types of ambulatory care programs as well as questions students should ask when researching post-graduate training. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The Impact of Disease Overestimation and Anchoring Bias in Antimicrobial Prescribing Behavior

Accuracy in diagnosis is critical for treating infectious diseases. In honor of U.S. Antibiotic Awareness Week (November 18-24, 2021), this Therapeutic Thursday podcast episode features an expert from the CDC and a physician and epidemiologist from the University of Maryland School of Medicine in Baltimore, Maryland. Our guests discuss diagnostic and antibiotic stewardship and how disease overestimation during diagnosis impacts antimicrobial prescribing behaviors. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Advantage: C diff Infection: What you need to know!

Learn from experts in the field on contemporary diagnosis and management of C diff infection. Topics include new diagnostic strategies and best treatment plans for our patients.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

(Management Case Study) Transitioning Specialty Pharmacy Services to Telemedicine for Embedded Clinical Pharmacists Within Various Specialty Clinics During the COVID-19 Pandemic

Embedded Clinical Pharmacists at Penn Presbyterian Medical Center’s clinics serve as members of an interdisciplinary team that confirm clinical appropriateness of specialty medications, ensure medication access, provide medication counseling and the specialty pharmacy complies with Utilization Review Accreditation Commission (URAC) regulations to maintain accreditation status. With the advent of COVID-19, these serves shifted to a telemedicine approach. In her 2020 Midyear Clinical Meeting presentation, Dr. Diane Kim shares her institution’s successes with transition and how her team demonstrated value to the specialty services.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Clinical Highlights from the 2020 Midyear: Adding It Up: Applying New Data to Management of Pediatric ADHD

This session from the 2020 Midyear Clinical Meeting, planned in cooperation with the ASHP Section of Clinical Specialists and Scientists, features a review of recent updates to the ADHD treatment guidelines and compares and contrasts newer formulations of ADHD medications.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Progressive Models for Underserved Patients in Rural Health Settings

Brought to you by the Section of Ambulatory Care Practitioners, this podcast episode features excerpts from the 2020 Midyear Clinical Meeting Design disease focused progressive pharmacy care models for a rural population and features virtual or telehealth models to reach rural-based populations, examples of standardized approaches for key rural practice areas, and identifies barriers faced in rural care settings.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.